about
OmniAb Inc licenses discovery research technology to pharmaceutical and biotech companies and academic institutions to enable the discovery of next-generation therapeutics. Its technology platform creates and screens diverse antibody repertoires and ...
Read More
2.14
0.03
(1.42%)
546.0K
XNAS Volume
XNAS 14 Jul, 2026 5:30 PM (EDT)
Not Eligible
Expensive Valuation
Technically Neutral
OmniAb Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..